Yong Kit Chin

Yong Kit Chin

Auto-generated profile, based on publicly available information

Yong Kit Chin

Aquatic Animal Health and Therapeutics Laboratory, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
WHWan Omar Haifa-Haryani
Wan Omar Haifa-Haryani
MAMd. Ali Amatul-Samahah
Md. Ali Amatul-Samahah
MAMohamad Azzam-Sayuti
Mohamad Azzam-Sayuti
YCYong Kit Chin
Yong Kit Chin
MSMOHD Zamri SAAD
MOHD Zamri SAAD
IYIna Salwany Md Yasin
Ina Salwany Md Yasin
Vibrio is the most common bacterium associated with diseases in crustaceans. Outbreaks of vibriosis pose a serious threat to shrimp production. Therefore, antibiotics are commonly used as preventative and therapeutic measures. Unfortunately, improper use of antibiotics leads to antibiotic resistance. Nevertheless, information on the occurrence of Vibrio spp. and antibiotic use in shrimp, particularly in Malaysia, is minimal. This study aimed to provide information on the occurrence of Vibrio spp., its status of antibiotic resistance and the plasmid profiles of Vibrio spp. isolated from cultured shrimp in Peninsular Malaysia. Shrimp were sampled from seven farms that were located in different geographical regions of Peninsular Malaysia. According to the observations, 85% of the shrimp were healthy, whereas 15% were unhealthy. Subsequently, 225 presumptive Vibrio isolates were subjected to biochemical tests and molecular detection using the pyrH gene. The isolates were also tested for antibiotic susceptibility against 16 antibiotics and were subjected to plasmid profiling. Eventually, 13 different Vibrio spp. were successfully isolated and characterized using the pyrH gene. They were the following: V. parahaemolyticus (55%), V. communis (9%), V. campbellii (8%), V. owensii (7%), V. rotiferianus (5%), Vibrio spp. (4%), V. alginolyticus (3%), V. brasiliensis (2%), V. natriegens (2%), V. xuii (1%), V. harveyi (1%), V. hepatarius (0.4%) and P. damselae (3%). Antibiotic susceptibility profiles revealed that all isolates were resistant to penicillin G (100%), but susceptible to norfloxacin (96%). Furthermore, 16% of the isolates revealed MAR of less than 0.2, while 84% were greater than 0.2. A total of 125 isolates harbored plasmids with molecular weights between 1.0 and above 10 kb, detected among the resistant isolates. The resistant isolates were mediated by both chromosomal and plasmid factors. These findings support the use of surveillance data on the emerging patterns of antimicrobial-resistance and plasmid profiles of Vibrio spp. in shrimp farms. The findings from this study can be used to develop a better disease management strategy for shrimp farming.

17 November 2021 in Biology
Verified
Journal Article
Open access
PDF file
MAMohamad Azzam-Sayuti
Mohamad Azzam-Sayuti
IYIna Salwany Md Yasin
Ina Salwany Md Yasin
MSMOHD Zamri SAAD
MOHD Zamri SAAD
Annas SallehAnnas Salleh
Annas Salleh
MYMohd Termizi Yusof
Mohd Termizi Yusof
Mohammad Noor Amal AzmaiMohammad Noor Amal Azmai
Mohammad Noor Amal Azmai
The genus Aeromonas has been recognised as an important pathogenic species in aquaculture that causes motile Aeromonas septicaemia (MAS) or less severe, chronic infections. This study compares the pathogenicity of the different Aeromonas spp. that were previously isolated from freshwater fish with signs of MAS. A total of 124 isolates of Aeromonas spp. were initially screened for the ability to grow on M9 agar with myo-inositol as a sole carbon source, which is a discriminatory phenotype for the hypervirulent A. hydrophila (vAh) pathotype. Subsequently, LD50 of six selected Aeromonas spp. were determined by intraperitoneal injection of bacterial suspension containing 103, 105, and 107 CFU/mL of the respective Aeromonas sp. to red hybrid tilapias. The kidneys, livers and spleens of infected moribund fish were examined for histopathological changes. The screening revealed that only A. dhakensis 1P11S3 was able to grow using myo-inositol as a sole carbon source, and no vAh strains were identified. The LD50–240h of A. dhakensis 1P11S3 was 107 CFU/mL, while the non-myo-inositol utilizing A. dhakensis 4PS2 and A. hydrophila 8TK3 was lower at 105 CFU/mL. Similarly, tilapia challenged with the myo-inositol A. dhakensis 1P11S3 showed significantly (p < 0.05) less severe signs, gross and histopathological lesions, and a lower mortality rate than the non-myo-inositol A. dhakensis 4PS2 and A. hydrophila 8TK3. These findings suggested that myo-inositol utilizing A. dhakensis 1P11S3 was not a hypervirulent Aeromonas sp. under current experimental disease challenge conditions, and that diverse Aeromonas spp. are of concern in aquaculture farmed freshwater fish. Therefore, future study is warranted on genomic level to further elucidate the influence of myo-inositol utilizing ability on the pathogenesis of Aeromonas spp., since this ability correlates with hypervirulence in A. hydrophila strains.

30 October 2019 in Aquaculture Research
Verified
Journal Article
Closed access
PDF file
YCYong Kit Chin
Yong Kit Chin
NANurhidayu Al‐Saari
Nurhidayu Al‐Saari
ZZZarirah Zulperi
Zarirah Zulperi
AMAslizah Mohd‐Aris
Aslizah Mohd‐Aris
ASAnnas Salleh
Annas Salleh
IYIna Salwany Md Yasin
Ina Salwany Md Yasin

24 May 2023 in Aquaculture Research
Verified
Journal Article
Open access
PDF file
MMMohd Hafiz Ngoo Muhamad-Sofie
Mohd Hafiz Ngoo Muhamad-Sofie
AMAslah Mohamad
Aslah Mohamad
MAMohamad Azzam-Sayuti
Mohamad Azzam-Sayuti
JLJing Yie Lee
Jing Yie Lee
WHWan Omar Haifa-Haryani
Wan Omar Haifa-Haryani
IYIna Salwany Md Yasin
Ina Salwany Md Yasin
Vibriosis causes a major setback in the marine aquaculture industry. In controlling vibriosis, vaccination of the broodstock could help in transferring the initial immunity to the fry and perhaps giving immunity to them during the culture period. This study determines the efficacy of three live-attenuated Vibrio harveyi vaccine (LAVh) derivatives on zebrafish broodstock in providing immunological protection to their offspring against pathogenic Vibrio spp. Zebrafish were vaccinated intraperitoneally with full effective dose (ED80) and monitored for 14weeks. On week 6, the specimens were intraperitoneally (i.p.) challenged with pathogenic 107CFU/ml of Vibrio spp., and subsequently another batch was left to spawn. Thereafter, the antibody level of larvae was monitored for 4weeks post-hatching. Groups of juvenile zebrafish were given booster vaccination via immersion (1×107CFU/mL) with vaccines similar to their predecessor. The fish were sampled weekly for four weeks to determine their antibody profile and pro-inflammatory gene expression. Finally, at week 3, the juvenile fish were challenged with pathogenic strains of Vibrio spp. Results of antibody profiling in the adult zebrafish model indicated that freeze-dried and stale LAVh delivers a longer immunological protective duration, while the FKVh vaccination group failed to provide immunological protection against V. alginolyticus. However, the gene expression of pro-inflammatory interleukin 1β (IL-1β) in the FKVh vaccinated group was elevated longer than that in the freeze-dried LAVh vaccinated group. Nevertheless, the relative percent survival (RPS) of both vaccination groups against pathogenic Vibrio spp. displayed 100 immunity. Overall, the freeze-dried LAVh vaccine was found to confer maternal immune protection for its offspring, provide a long duration of immunological protection and cross-protection coverage against pathogenic Vibrio spp., and have a longer shelf life. It is proposed to be commercially available for farmers to protect against Vibrio spp. infection.

1 January 2026 in Aquaculture Research
Verified
Journal Article
Open access
AMAslah Mohamad
Aslah Mohamad
ZAZahaludin Amir-Danial
Zahaludin Amir-Danial
Mohammad Noor Amal AzmaiMohammad Noor Amal Azmai
Mohammad Noor Amal Azmai
MSMOHD Zamri SAAD
MOHD Zamri SAAD
Annas SallehAnnas Salleh
Annas Salleh
IYIna Salwany Md Yasin
Ina Salwany Md Yasin
Vibriosis, caused by Vibrio spp ., poses a significant challenge in marine aquaculture, leading to severe economic losses. Vaccination has emerged as a safer and more effective alternative to antibiotics for disease control, with oral vaccination offering advantages such as ease of administration and scalability for large‐scale aquaculture operations. This study evaluated the efficacy of an oral inactivated Vibrio harveyi vaccine in a field environment with cage‐cultured Asian seabass ( Lates calcarifer ) at Pulau Ketam, Klang, Selangor, Malaysia. Fish were divided into two groups: (1) a vaccinated group fed a commercial diet supplemented with formalin‐killed V. harveyi (10 8 CFU/mL) and palm oil as an adjuvant and (2) a placebo control group fed a commercial diet supplemented with phosphate‐buffered saline (PBS) and palm oil adjuvant. The vaccine was administered orally at weeks 0, 2, and 6 for three consecutive days at a dosage of 4% of the fish’s body weight. Immune‐related gene expression, including dendritic cells (DCs), complement factor 3 (C3), chemokine ligand 4 (CCL4), tumor necrosis factor‐α (TNF‐α), and immunoglobulin‐T (IgT), was significantly upregulated ( p < 0.05) in vaccinated fish compared to controls, with peak expression observed following booster doses. At week 10, a laboratory challenge trial with V. harveyi (1 × 10 8 CFU/mL) demonstrated an 80% relative percentage survival (RPS) in the vaccinated group, whereas the unvaccinated group exhibited 100% mortality. In addition, vaccinated fish displayed reduced clinical signs following infection. These findings highlight the potential of oral inactivated V. harveyi vaccines to induce robust immune responses and confer effective protection against vibriosis in Asian seabass. This approach provides a practical and scalable solution for disease management in marine aquaculture, improving health outcomes and productivity for fish farmers.